Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-12-04
1989-08-08
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514352, 546264, 546304, 546309, 546312, C07D21361, A61K 3144
Patent
active
048553085
ABSTRACT:
A method is disclosed for the treatment or amelioration of the symptoms of cerebral insufficiency characterized by decreased central adrenergic and/or cholinergic function employing certain N-substituted aminopyridines.
REFERENCES:
patent: 3450707 (1969-06-01), Bailey
patent: 3624096 (1971-11-01), Abramovitch
patent: 3928341 (1975-12-01), Delarue
patent: 4206215 (1980-06-01), Bailey
patent: 4331670 (1982-05-01), Nishiyama
Hirota et al., Bull. Soc. Chem. (Japan), 54:1583-1584.
Sammes, et al., J. Med. Soc. Perkin Trans. I, (1983), 973-978.
Kester Jeffrey A.
Moos Walter H.
Thomas Anthony J.
Daignault Ronald A.
Lee Mary C.
Northington Zinna
Warner-Lambert & Company
LandOfFree
Method of treating senile cognitive decline with N'-substituted does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating senile cognitive decline with N'-substituted , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating senile cognitive decline with N'-substituted will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-905813